COVID-19 Resources

As we all work to navigate the impact of COVID-19 on the health care sector and how care is delivered, ASPL wants to ensure our members have access to valuable resources to help you manage guidance being issued related to this pandemic.  If your organization has resources it would like to share, please forward the information to [email protected].

National Alliance of State Pharmacy Associations -
Bula Intelligence - Bula Blog
Faegre Drinker - Coronavirus (COVID-19) Resource Center
Hall Render - COVID-19 Resource Center
National Alliance of State Pharmacy Associations - COVID-19 State Rulings
National Association of Boards of Pharmacy - COVID-19 Resource Center
Quarles & Brady - COVID-19: Guidance for Clients



The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a nonprofit organization with the purposes of

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

September 21, 2020

Justice Ginsburg’s impact on health care jurisprudence

As the nation mourns the loss of Supreme Court Justice Ruth Bader Ginsburg, and reflects on her life and contributions, a review of her positions on issues involving  health care can be found at the website. Among the positions taken by Justice Ginsburg that are summarized on the site are the following:

  • ACA individual mandate is constitutional under Commerce Clause (National Federation of Independent Business v. Sebelius, 2012; joined majority)
  • States have authority to protect patient rights, not preempted by ERISA (Rush Prudential HMO v. Moran, 2002; joined majority)
  • States decide insurance issues, not federal government; under Federal Employees Health Benefits Act states are the proper venue for suits by federal beneficiaries against insurers (Empire HealthChoice Assurance v. McVeigh, 2006; wrote majority opinion)
  • Congress didn’t intend disparate result on product liability for generic drugs (Pliva v. Mensing, 2011; joined dissent) [Ruth Bader Ginsburg on Health Care,, accessed 21 Sep 20;]